AZM

5-ACETAMIDO-1,3,4-THIADIAZOLE-2-SULFONAMIDE

AZM is found in 28 entries

AZM as free ligands, exist in 28 entries. Examples include 1AZM, 1DMY, 1JD0

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo

Chemical Component Summary

Name 5-ACETAMIDO-1,3,4-THIADIAZOLE-2-SULFONAMIDE
Identifiers N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide
N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)ethanamide
Formula C4 H6 N4 O3 S2
Molecular Weight 222.25 g/mol
Type non-polymer
Isomeric SMILES CC(=O)Nc1nnc(s1)S(N)(=O)=O
InChI InChI=1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9)
InChI Key BZKPWHYZMXOIDC-UHFFFAOYSA-N

Chemical Details

Formal Charge 0
Atom Count 19
Chiral Atom Count 0
Chiral Atoms
Bond Count 19
Aromatic Bond Count 5

Drug Info: DrugBank

DrugBank ID DB00819   (Stereoisomeric match)
Name Acetazolamide
Groups approved
Description One of the carbonic anhydrase inhibitors that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Synonyms
  • 2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide
  • 5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide
  • 5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide
  • Acetazolamid
  • Acetazolamida
  • Acétazolamide
  • Acetazolamidum
  • Defiltran
  • Diacarb
  • Diamox
  • Diluran
  • Glaupax
  • N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide
  • N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide
[more]
Salts Acetazolamide Sodium
Brand Names
  • Acetazolam
  • Acetazolamide
  • Acetazolamide for Injection, USP
  • Diamox IV 500mg
  • Diamox Pws 500mg/vial
  • Diamox Sequels
  • Diamox Src 500mg
  • Diamox Tab 250mg
  • Diamox Tablets 250mg
  • Novo-zolamide Tab 250mg
  • Acemit
  • Acemox
  • Acetak
  • Acetamide
  • Acetazolamax
  • Azm
  • Azol
  • Azomid
  • Carbinib
  • Defiltran
  • Diabo
  • Diacarb
  • Diamox
  • Diamox Depot
  • Diazomid
  • Diluran
  • Diuramid
  • Défiltran
  • Edemox
  • Glaumox
  • Glaupax
  • Glupax
  • Huma-Zolamide
  • Iopar-SR
  • Medene
  • Oculten
  • Uramox
  • Zolmide
  • Ödemin
[more]
Affected Organism Humans and other mammals
Indication For adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies; chronic simple (open-angle) glaucoma
Pharmacology Acetazolamide is a potent carbonic anhydrase inhibitor, effective in the control of fluid secretion, in the treatment of certain convulsive disorders and in the promotion of diuresis in instances of abnormal fluid retention. Acetazolamide is not a mercurial diuretic. Rather, it is a nonbacteriostatic sulfonamide possessing a chemical structure and pharmacological activity distinctly different from the bacteriostatic sulfonamides.
Mechanism of action The anticonvulsant activity of Acetazolamide may depend on a direct inhibition of carbonic anhydrase in the CNS, which decreases carbon dioxide tension in the pulmonary alveoli, thus increasing arterial oxygen tension. The diuretic effect depends on the inhibition of carbonic anhydrase, causing a reduction in the availability of hydrogen ions for active transport in the renal tubule lumen. This leads to alkaline urine and an increase in the excretion of bicarbonate, sodium, potassium, and water.
Route of administration
  • intravenous
  • oral
Categories
  • Diuretics
  • Anticonvulsants
  • Carbonic Anhydrase Inhibitors
ATC-Code S01EC01
AHFS-Code 52:10.00
CAS number 59-66-5
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682